Charming Medical Ltd (MCTA) Cash Flow Statement
Charming Medical Ltd (MCTA) generated -$1.2M of operating cash flow over the twelve months to its latest filing, spent $339560 on capital expenditure and had free cash flow of -$1.6M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · read by EquiReason
MCTACharming Medical LtdFollow MCTA — free
—
Price chart with a free account
- Market cap
- 504.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- —
| Line | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM | Trend |
|---|---|---|---|---|---|
| Operating cash flow | 0.3 | 0.4 | -1.2 | -1.2 | |
| Capital expenditure | 0.2 | 0.3 | 0.3 | -0.3 | |
| Free cash flow | 0.1 | 0.1 | -1.6 | -1.6 |
USD millions · SEC XBRL
Charming Medical Ltd — questions
- What is Charming Medical Ltd's operating cash flow?
- -$1.2M over the twelve months to the latest filing.
- How much does Charming Medical Ltd spend on capital expenditure?
- $339560 over the twelve months to the latest filing.
- What is Charming Medical Ltd's free cash flow?
- -$1.6M over the twelve months to the latest filing: operating cash flow minus capital expenditure.
Every figure on this page comes from Charming Medical Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.